medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2021, Number 6

<< Back Next >>

Salud Mental 2021; 44 (6)

Beck Depression Inventory (BDI-IA) adapted for HIV: Psychometric properties, sensitivity & specificity in depressive episodes, adjustment disorder & without symptomatology

Rodríguez-Pérez V, Piñeirua MA, Ramírez-Rentería C, Mata MJA

Language: English
References: 45
Page: 287-294
PDF size: 229.95 Kb.


ABSTRACT

Introduction. The Beck Depression Inventory (BDI-IA) is the most widely used instrument for assessing depression symptoms. Although it has been validated in the Mexican population, it has not been tested in people living with HIV (PLWH), who tend to have symptoms difficult to distinguish from those associated with viral infection. Objective. We obtained the psychometric properties, sensitivity, specificity, and cut-off points to distinguish between a depressive episode, adjustment disorder and no symptoms. Method. Prospective study with 2,022 PLWH (88% men), who completed the BDI-IA between 2016 and 2017. Subjects had a mean age of 31.9 ± 9.3 years, with 12.0 ± 5.6 years of schooling, and 4.5 ± 4.3 years since diagnosis. The differentiation of items, internal consistency, factor analysis, and calculation of sensitivity and specificity were tested. Results. A Cronbach’s alpha coefficient of .91 was obtained. Through factorial analysis with orthogonal rotation (average intercorrelations r = .40, KMO .929), we obtained three factors: general factor of depression, somatic, and cognition, which explained 39.7%, 6.01%, and 5.49% of the variance, respectively. Only the items in the first factor (the short version with 12 items) were tested. With a cut-off point of 11, it had 85.5% sensitivity and 76% specificity [(AUC) = .865, 95% CI [.83, .90], p ≤ .001], and distinguished major depressive disorder from cases without mental symptoms. Discussion and conclusion. We show that the short version of the BDIIA is reliable, valid, sensitive, and specific for evaluating depression symptoms comorbid with HIV infection.


REFERENCES

  1. American Psychiatric Association. (2015). Depressive Disorders: DSM-5® Selections. American Psychiatric Pub.

  2. Bautista-Arredondo, S., Colchero, M. A., Romero, M., Conde-Glez, C. J., & Sosa- Rubí, S. G. (2013). Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men. PloS One, 8(9), e72616. doi: 10.1371/ journal.pone.0072616

  3. Beck, A. T., & Steer, R. A. (1984). Internal consistencies of the original and revised Beck Depression Inventory. Journal of Clinical Psychology, 40(6), 1365-1367. doi: 10.1002/1097-4679(198411)40:63.0.co;2-d

  4. Beck, A. T., Steer, R. A., & Carbin, M. G. (1988). Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review, 8(1), 77-100. doi: 10.1016/0272-7358(88)90050-5

  5. Beltrán, M. D. C., Freyre, M. Á., & Hernández-Guzmán, L. (2012). El Inventario de Depresión de Beck: Su validez en población adolescente. Terapia Psicológica, 30(1), 5-13. doi: 10.4067/S0718-48082012000100001

  6. Berger-Greenstein, J. A., Cuevas, C. A., Brady, S. M., Trezza, G., Richardson, M. A., & Keane, T. M. (2007). Major depression in patients with HIV/AIDS and substance abuse. AIDS Patient Care and STDs, 21(12), 942-955. doi: 10.1089/ apc.2006.0153

  7. Byrne, B. M. (2010). Structural equation modeling with AMOS Basic concepts, applications, and programming (Multivariate Applications Series). Routledge/ Taylor & Francis Group.

  8. Carretero-Dios, H., & Pérez, C. (2005). Normas para el desarrollo y revisión de estudios instrumentales. International Journal of Clinical and Health Psychology, 5(3), 521-551.

  9. Centro Nacional para la Prevención y el Control del VIH/SIDA [CENSIDA]. (2018a). Vigilancia Epidemiológica de casos de VIH/SIDA en México, Registro Nacional de Casos de SIDA, actualización al 1er. trimestre del 2018. México: Censida/Secretaría de Salud. Retrieved from https://www.gob.mx/cms/uploads/ attachment/file/328400/RN_1er_trim_2018.pdf

  10. Centro Nacional para la Prevención y Control del VIH/SIDA [CENSIDA]. (2018b). Guía de manejo antirretroviral de las personas con VIH, 8ª Edición. México: Censida/Secretaría de Salud. Retrieved from https://www.gob.mx/cms/uploads/ attachment/file/326631/Gu_a_ARV_2018.pdf

  11. Chichetto, N. E., Polanka, B. M., So-Armah, K. A., Sung, M., Stewart, J. C., Koethe, J. R., & Freiberg, M. S. (2020). Contribution of Behavioral Health Factors to Non-AIDS-Related Comorbidities: An Updated Review. Current HIV/AIDS Reports, 17(4):354-372. doi: 10.1007/s11904-020-00498-y

  12. Ciesla, J. A., & Roberts, J. E. (2001). Meta-analysis of the relationship between HIV infection and risk for depressive disorders. American Journal of Psychiatry, 158(5), 725-730. doi: 10.1176/appi.ajp.158.5.725

  13. Dávila, Y., Castellanos, M., & García, M. (2015). National strategy of integrated care for tuberculosis and HIV co-infection in Mexico, progress in 2015/. International Journal of Integrated Care, 15(8).

  14. DiPrete, B. L., Pence, B. W., Grelotti, D. J., & Gaynes, B. N. (2018). Measurement of depression treatment among patients receiving HIV primary care: Whither the truth? Journal of Affective Disorders, 230, 50-55. doi: 10.1016/j.jad.2017.12.068

  15. Engler, K., Lènàrt, A., Lessard, D., Toupin, I., & Lebouché, B. (2018). Barriers to antiretroviral therapy adherence in developed countries: a qualitative synthesis to develop a conceptual framework for a new patient-reported outcome measure. AIDS Care, 30(sup1), 17-28. doi: 10.1080/09540121.2018.1469725

  16. Eshun-Wilson, I., Siegfried, N., Akena, D. H., Stein, D. J., Obuku, E. A., & Joska, J. A. (2018). Antidepressants for depression in adults with HIV infection. The Cochrane Database of Systematic Reviews, 1(1), CD008525. doi: 10.1002/14651858.CD008525.pub3

  17. Gebreyesus, T., Belay, A., Berhe, G., & Haile, G. (2020). Burden of fatigue among adults living with HIV/AIDS attending antiretroviral therapy in Ethiopia. BMC Infectious Diseases, 20(1), 1-10. doi: 10.1186/s12879-020-05008-4

  18. Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011). Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 58(2). doi: 10.1097/ QAI.0b013e31822d490a

  19. González-Celis Rangel, A. L. (2009). Composición factorial del inventario de depresión de Beck en ancianos mexicanos. Journal of Behavior, Health & Social Issues, 1(1), 15-28.

  20. Govender, R. D., & Schlebusch, L. (2012). Hopelessness, depression, and suicidal ideation in HIV-positive persons. South African Journal of Psychiatry, 18(1), 16-21. doi: 10.4102/sajpsychiatry.v18i1.302

  21. Guillemin, F. (1995). Cross-cultural adaptation and validation of heatth status measures. Scandinavian Journal of Rheumatology, 24(2), 61-63. doi: 10.3109/03009749509099285

  22. Hammond, E. R., Crum, R. M., Treisman, G. J., Mehta, S. H., Clifford, D. B., Ellis, R. J., & Morgello, S. (2016). Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depression symptoms, a prospective cohort study. Journal of Neurovirology, 22(4), 479-487. doi: 10.1007/s13365-015-0416-1

  23. Hudelson, C., & Cluver, L. (2015). Factors associated with adherence to antiretroviral therapy among adolescents living with HIV/AIDS in low-and middleincome countries: a systematic review. AIDS Care, 27(7), 805-816. doi: 10.1080/09540121.2015.1011073

  24. Jurado, S., Villegas, M. E., Méndez, L., Rodríguez, F., Loperena, V., & Varela, R. (1998). La estandarización del Inventario de Depresión de Beck para los residentes de la Ciudad de México. Salud Mental, 21(3), 26-31.

  25. Kalichman, S. C., Rompa, D., & Cage, M. (2000). Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. The Journal of Nervous and Mental Disease, 188(10), 662- 670. doi: 10.1097/00005053-200010000-00004

  26. Mendoza, J. E. V., Ramírez, M. C., & Morales, J. E. A. (2013). Estrategias de afrontamiento del sida en pacientes diagnosticados como seropositivos. Psicología y Salud, 19(2), 215-221. doi: 10.25009/pys.v19i2.631

  27. Muhktar, F., & Oei, T. P. (2008). Exploratory and confirmatory factor validation and psychometric properties of the Beck Depression Inventory for Malays (BDIMalay) in Malaysia. Malaysian Journal of Psychiatry, 17(1).

  28. Nanni, M. G., Caruso, R., Mitchell, A. J., Meggiolaro, E., & Grassi, L. (2015). Depression in HIV infected patients: a review. Current Psychiatry Reports, 17(1), 530. doi: 10.1007/s11920-014-0530-4

  29. Nunnally, J. C., & Bernstein, Y. J. (1994). Psychometric Theory (3rd Ed). New York: McGraw Hill.

  30. Pala, A. N., Steca, P., Bagrodia, R., Helpman, L., Colangeli, V., Viale, P., & Wainberg, M. L. (2016). Subtypes of depressive symptoms and inflammatory biomarkers: an exploratory study on a sample of HIV-positive patients. Brain, Behavior, and Immunity, 56, 105-113. doi: 10.1016/j.bbi.2016.02.013

  31. Perazzo, J. D., Currie, J., Horvat Davey, C., Lambert, J., & Webel, A. R. (2020). Depression and social capital in people living with HIV. Journal of Psychiatric and Mental Health Nursing, 27(1), 54-61. doi: 10.1111/jpm.12552

  32. Reyes-Lagunes, I., & García y Barragán, L. F. (2008). Procedimiento de validación psicométrica culturalmente relevante: Un ejemplo. In S. Rivera Aragón, R. Díaz Loving, R. Sánchez Aragón, I. Reyes Lagunes (Eds.). La psicología social en México, XII (pp. 625-630). México: AMEPSO, Universidad de Guanajuato y UNAM.

  33. Rodríguez, V., Magis, C., Casillas, J., Ramirez, H. V., Hernandez, G., Rentería, C. R., & Gonzalez, A. (2012). Internal consistency and factorial structure of the Beck Depression Inventory (BDI) in Mexican HIV-positive patients. Poster at XIX International AIDS Conference July (pp. 22-27).

  34. Sowa, N. A., Bengtson, A., Gaynes, B. N., & Pence, B. W. (2016). Predictors of depression recovery in HIV-infected individuals managed through measurementbased care in infectious disease clinics. Journal of Affective Disorders, 192, 153-161. doi: 10.1016/j.jad.2015.12.031

  35. Steer, R. A., Clark, D. A., Beck, A. T., & Ranieri, W. F. (1999). Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDIIA. Behaviour Research and Therapy, 37(2), 183-190. doi: 10.1016/s0005- 7967(98)00087-4

  36. Torres-Castillo, M., Hernández-Malpica, E., & Ortega-Soto, H. A. (1991). Validez y reproducibilidad del inventario para Depresión de Beck, en un hospital de cardiología. Salud Mental, 14(2), 1-6.

  37. Tsai, A. C. (2014). Reliability and validity of depression assessment among persons with HIV in sub-Saharan Africa: systematic review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 66(5), 503-511. doi: 10.1097/ QAI.0000000000000210 Turan, B., Rice, W. S., Crockett, K. B., Johnson, M., Neilands, T. B., Ross, S. N., ...

  38. Turan, J. M.. (2019). Longitudinal association between internalized HIV stigma and antiretroviral therapy adherence for women living with HIV: the mediating role of depression. Aids, 33(3), 571-576. doi: 10.1097/QAD.0000000000002071

  39. Uthman, O. A., Magidson, J. F., Safren, S. A., & Nachega, J. B. (2014). Depression and adherence to antiretroviral therapy in low-, middle-and high-income countries: a systematic review and meta-analysis. Current HIV/AIDS Reports, 11(3), 291-307. doi: 10.1007/s11904-014-0220-1

  40. Valdés, C., Morales-Reyes, I., Pérez, J. C., Medellín, A., Rojas, G., & Krause, M. (2017). Propiedades psicométricas del Inventario de Depresión de Beck IA para la población chilena. Revista Médica de Chile, 145(8), 1005-1012.

  41. Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., ... Duan, L. (2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 386(9995), 743-800. doi: 10.1016/S0140-6736(15)60692-4.

  42. White, J. R., Chang, C. C. H., So-Armah, K. A., Stewart, J. C., Gupta, S. K., Butt, A. A., ... Freiberg, M. S. (2015). Depression and human immunodeficiency virus infection are risk factors for incident heart failure among veterans: Veterans Aging Cohort Study. Circulation, 132(17), 1630-1638. doi 10.1161/ CIRCULATIONAHA.114.014443

  43. Wolff, C., Alvarado, R., & Wolff, M. (2010). Prevalencia, factores de riesgo y manejo de la depresión en pacientes con infección por VIH: Revisión de la literatura. Revista Chilena de Infectología, 27(1), 65-74.

  44. World Health Organization. (2000). Guía de bolsillo de la clasificación CIE-10: clasificación de los trastornos mentales y del comportamiento. Editorial Médica Panamericana.

  45. World Medical Association. (2013). World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Journal of the American Medical Association, 310(20), 2191-2194. doi: 10.1001/jama.2013.281053.




2020     |     www.medigraphic.com